Assessment of Walking-related Fatigability in Patients With Multiple S
Clinical Profiling, Manifestation and Assessment of Walking-related Performance Fatigability in Patients With Multiple Sclerosis: a Cross Sectional Study
What it found
A paper reports the results; we have not read it yet. See Papers below.
What was tested
Treatment tested
- Assessment of walking-related fatigability
What it measured
Main measures
Deceleration index
day 1
Walking and mobility
Other measures (15)
Symptom Inventory Questionnaire
day 1
Thinking and memoryFatigueWalking and mobilitySpasticityPainSymptom Inventory Questionnaire
day 4
Thinking and memoryFatigueWalking and mobilitySpasticityPainspasticity
day 1
Walking and mobilitySpasticityspasticity
day 4
Walking and mobilitySpasticityStrength
day 1
Walking and mobilityPhysical functionStrength
day 4
Walking and mobilityPhysical functionBalance
day 1
Walking and mobilityBalance
day 4
Walking and mobilityVAS fatigue
day 1
FatigueWalking and mobilityVAS fatigue
day 4
FatigueWalking and mobility
Who could take part
MS (type not specified) · 18 to 70
Show the full criteria
Inclusion criteria
* Age between 18 - 70 years * Confirmed diagnosis according to the McDonald criteria * Performed a 6MWT before, to ensure familiarization * Able to walk independently or with unilateral support for 6 minutes without rest * Signed the informed consent
Exclusion criteria
* Exacerbation or relapse within last 3 months before study * Other neurological diagnosis, such as stroke and Parkinson * MS-like syndromes, such as neuromyelitis optica * Other medical condition interfering with walking ability (e.g. cardiac or respiratory diseases, arthritis and fibromyalgia)
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The primary goal of this interventional study is to objectively examine the prevalence of walking-related performance fatigability, together with the psychometric properties of its measuring parameters. The secondary aim is to investigate the relation of other clinical symptoms to walking-related performance fatigability. The following three research questions will be addressed: 1. How prevalent is walking-related performance fatigability and what are the psychometric properties of fatigability formulas in preparation of use as experimental outcome measure? 2. What are associated symptoms of walking-related motor fatigability and how long does this manifest? 3. What is the relationship between cognitive fatigability and walking-related performance fatigability? participants perform two six-minute walking test (6MWT), with 3-5 days in between. Before and after the 6MWT, three screenings test (spasticity, muscle strength, balance) are executed and the participants have to indicate the severity of eleven possible symptoms (= symptom inventory, SI) on a VAS scale. These screening tests and SI are continued every 10 minutes for half an hour. During a third test session, participants perform a 6-minute vigilance alphabet test in rest and while doing a 6MWT to investigate the relationship between cognitive and motor fatigability.
Papers
Results
Van Geel F, Bielen H, Theunissen K, Moumdjian L, Van Nieuwenhoven J, Van Wijmeersch B, Meesen R, Ramari C, Feys P. Clinical manifestation and perceived symptoms of walking-related performance fatigability in persons with multiple sclerosis. Int J Rehabil Res. 2021 Jun 1;44(2):118-125. doi: 10.1097/MRR.0000000000000457.Results
Van Geel F, Veldkamp R, Severijns D, Dalgas U, Feys P. Day-to-day reliability, agreement and discriminative validity of measuring walking-related performance fatigability in persons with multiple sclerosis. Mult Scler. 2020 Nov;26(13):1785-1789. doi: 10.1177/1352458519872465. Epub 2019 Sep 9.
Loading reviews and guidelines…
History
Started
Dec 2017
Main results due
May 2018
Finished
May 2018